Aug. 03, 2021 10:28

From Panasonic i-PRO Sensing Solutions to “i-PRO”, Renewing Its Company Name From April 2022

Panasonic i-PRO Sensing Solutions Co., Ltd. will renew its company name to “i-PRO Co., Ltd.” on April 1, 2022. Our company was established in October 2019 as a business separation from Panasonic Corporation, and we have incorporated the network ca...

Aug. 03, 2021 09:50

Lenovo Climbs 65 Places to Record #159 On ‘FORTUNE Global 500’ List

After achieving historical 2021 fiscal year results, Lenovo has been ranked #159 on FORTUNE’s annual Global 500 List and in the top 20 (#15) of all Technology sector companies cited in the List. Lenovo jumped 65 spots this year to an all-time high...

Aug. 02, 2021 17:00

Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the receipt of a decision by the Irish Tax Appeals Commission on July 30, 2021 (IST) to uphold the Irish Revenue Commissioners’ position related to the treatment ...

Aug. 02, 2021 15:50

NIH Advances ACTIV-5/BET-B Trial Evaluating Lenzilumab from a Phase 2 Exploratory Study to a Phase 2/3 Study for the Treatment of COVID-19

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company developing a first-in-class GM-CSF neutralizing antibody to prevent and treat an immune hyper-response called ‘cytokine storm’ across multiple therapeutic ind...

Aug. 02, 2021 13:50

I’mbesideyou Inc. Launched “UNION OF EMOTIONS” Service Using AI to Visualize Cheering Each Other Across National Borders

I’mbesideyou Inc. (Setagaya-ku, Tokyo CEO: Shozo Kamiya, hereinafter referred to as I'mbesideyou) launched the “UNION OF EMOTIONS” service on July 23, 2021, the opening day of an international sporting event. This is the first time we have been ab...

Aug. 02, 2021 13:40

ENYO Pharma Announces 16 Weeks Vonafexor (EYP001) Top-Line Interim Results from Two on-going Phase 2a Studies in Chronic Hepatitis B Patients

ENYO Pharma (ENYO), a private clinical stage biotechnology company developing innovative drug candidates, today announced positive proof of concept data from Study EYP001-203 of Vonafexor in combination with pegylated-Interferon (peg-IFN) in virem...

Aug. 02, 2021 13:30

Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced financial results for the first quarter of fiscal year 2021 (period ended June 30, 2021). Based on the solid first-quarter results, the Company also confirmed i...

Aug. 02, 2021 11:53

Schneider Electric implements predictive maintenance for Nestlé’s Dubai South factory

The Nestlé Al Maha factory in Dubai is benefiting from an innovative approach to the maintenance of its Low Voltage electrical machinery, thanks to technology from Schneider Electric. The solution is helping Nestlé’s operations team monitor power ...

Aug. 02, 2021 10:40

Burgiss Appoints Head of Client Coverage for Asia Pacific

Burgiss, a leading provider of data, analytics and technology solutions for private capital investors, announced today that Wyn James has joined the company as Head of Client Coverage for the Asia Pacific region. Based in Singapore, Wyn will lead ...

Aug. 02, 2021 09:49

Wemade Co., Ltd. Announces Pre-Registration for MIR 4, an Open World K-Fantasy MMORPG

“From my battle to our war.” MIR 4, the unique open world K-Fantasy MMORPG, opened for global pre-registration on Thursday, 29 July. The game beautifully portrays the mystical and elegant life of the Orient, offering a truly singular experience fo...

Jul. 30, 2021 15:30

Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (Takeda) and Frazier Healthcare Partners (Frazier) today announced a collaboration to launch HilleVax, Inc. (HilleVax), a biopharmaceutical company to develop and commercialize Takeda’s nor...

Jul. 30, 2021 15:30

IWBI Collaborates with Leading Organizations to Launch WELL Enterprise Provider Designation

The International WELL Building Institute (IWBI) today launched the WELL Enterprise Provider (WELL EP) designation for organizations that demonstrate expertise for delivering a comprehensive suite of WELL solutions at a portfolio or enterprise sca...

Jul. 30, 2021 14:40

Velodyne Lidar Introduces Vella Development Kit for Building Autonomous Solutions

Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) today announced a new software development kit which allows customers to utilize the advanced capabilities of Velodyne’s Vella lidar perception software in their autonomous solutions. The Vella Developmen...

Jul. 30, 2021 14:20

Inmarsat Unveils the Communications Network of the Future

Today, Inmarsat unveiled plans for ORCHESTRA, the communications network of the future. In the largest ever transformation of its current world-class services, Inmarsat ORCHESTRA will bring together existing geosynchronous (GEO) satellites with lo...

Jul. 30, 2021 14:00

EML Awarded Northern Ireland Government Tender For AU$273million Economic Stimulus Solution

EML Payments (ASX: EML) (S&P/ASX 200) is delighted to win a tender to disburse an AU$273million economic stimulus boost to the citizens of Northern Ireland through Mastercard prepaid cards. The new High Street Scheme (HSS) will provide everyone re...

Jul. 30, 2021 14:00

Conviva and the Trade Desk Partner to Improve Contextual Advertising for Premium Streaming Publishers

Conviva, the intelligence cloud for streaming media, and global advertising technology leader The Trade Desk, have entered a first-of-its-kind partnership to provide the streaming advertising industry the contextual content signals needed in the b...

Jul. 30, 2021 13:20

Prokarium Appoints Uz Stammberger as Chief Medical Officer to Drive Clinical Development in Oncology

Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the appointment of Uz Stammberger, MD, as Chief Medical Officer. In the role, Dr. Stammberger will lead the advancement of Prokarium’s...

Jul. 30, 2021 12:00

Henley & Partners: Investment Migration: “We Need More, Not Less Immigration of People Who Contribute Positively to Society”

Henley & Partners Chairman Dr. Christian H. Kaelin says the significant worldwide expansion of investment migration, by which affluent individuals invest in other countries to acquire residence or citizenship, is simply unstoppable. Speaking at Th...

Jul. 30, 2021 11:10

Toshiba Releases Arm® Cortex®-M4 Microcontrollers for Motor Control as First Products in the TXZ+TM Family Advanced Class

Toshiba Electronic Devices & Storage Corporation (“Toshiba”) has started the mass production of 12 new devices in the M4K group for motor control as the first products of the TXZ+TM family advanced class, and will start mass production of another ...

Jul. 30, 2021 11:00

Kioxia Introduces New Retail SSDs for Next Generation and Mainstream PCs

Kioxia Corporation, a world leader in memory solutions, today announced two new solid state drive (SSD) series scheduled to be released in the fourth quarter of 2021. The EXCERIA PRO and EXCERIA G2 Series are the company’s latest consumer-grade so...

Jul. 30, 2021 10:40

Mekitec Acquires Grupo Bimbo’s AI-Focused Subsidiary

Food quality control system manufacturer Mekitec Group acquired Grupo Bimbo subsidiary Kanan Smart Solution on July 15, 2021, including a software development team and local sales and service operations in Mexico. This solidifies Mekitec’s place a...

Jul. 29, 2021 16:05

SES Enters Multi-transponder Agreement with NewSpace India Limited via SES-8

SES announced today that it had entered into a multi-transponder agreement for its SES-8 satellite with NewSpace India Limited (NSIL), a Central Public Sector Enterprise (CPSE) under Department of Space (DoS) based in Bengaluru, India. The nine-tr...

Jul. 29, 2021 15:30

ENYO Pharma Announces Positive Vonafexor (EYP001) Results for the LIVIFY Phase 2a Study in F2-F3 NASH Patients over 12 weeks

ENYO Pharma (ENYO), a private clinical stage biotechnology company developing innovative drug candidates, today announced that Vonafexor met the primary and several secondary endpoints in the LIVIFY clinical study conducted in F2-F3 Non Alcoholic ...

Jul. 29, 2021 14:30

Riskified Ltd. Announces Pricing of Initial Public Offering

Riskified Ltd. (“Riskified”), a fraud management platform enabling frictionless eCommerce, today announced the pricing of its initial public offering of 17,500,000 Class A ordinary shares at a public offering price of $21.00 per Class A ordinary s...

Jul. 29, 2021 14:15

Black & Veatch Guides Point-of-Use Hydrogen Production for Vehicle Fuel Study

Artificial Intelligence business Empati has commissioned Black & Veatch to deliver a study into the feasibility of using distributed production of green hydrogen to fuel vehicle fleets. Black & Veatch will provide an economic, logistical and techn...